4TEEN4 Pharmaceuticals GmbH
PrivateLast Round
Grant
Jul 2, 2026
Est. Valuation
$190.91M
Total Funding Raised
$90.38M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
4TEEN4 Pharmaceuticals GmbH is a biotechnology company that develops precision medicine therapies and diagnostic assays for the treatment of acute cardiovascular complications and circulatory shock.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
4TEEN4 Pharmaceuticals GmbH Comparables
Compare 4TEEN4 Pharmaceuticals GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adrenomed AG | 90% | |
| Matisse Pharmaceuticals | 80% | |
| Inotrem | 79% |
4TEEN4 Pharmaceuticals GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 2, 2026 | ||||
| Grant | Jun 17, 2026 | ||||
| Series C | Jul 31, 2024 | ||||
| Grant | Feb 29, 2024 | ||||
| Strategic | Feb 21, 2024 | ||||
Series B | Jan 31, 2024 |
Key People
Founding team and executive leadership
4TEEN4 Pharmaceuticals GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NRW.Venture | Series C |
| Brandenburg Kapital | Series C, Series A |
| Görlich GmbH & Co. 1. BioTech KG | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 23, 2026
Grew 16% QoQ, from 32 to 37 employees.
- Aug 21, 2026
Monthly visitors grew 1007% MoM, reaching 1.1K.
4TEEN4 Pharmaceuticals GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about 4TEEN4 Pharmaceuticals GmbH's valuation, stock price, and market status.
Is 4TEEN4 Pharmaceuticals GmbH a public or private company?
4TEEN4 Pharmaceuticals GmbH is a private company.
What is the current stock price of 4TEEN4 Pharmaceuticals GmbH?
4TEEN4 Pharmaceuticals GmbH is a private company, so its shares have no public market price. Caplight tracks 4TEEN4 Pharmaceuticals GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is 4TEEN4 Pharmaceuticals GmbH worth (valuation)?
4TEEN4 Pharmaceuticals GmbH's valuation is estimated at $190.9M based on funding round data.
Can I buy 4TEEN4 Pharmaceuticals GmbH stock?
4TEEN4 Pharmaceuticals GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was 4TEEN4 Pharmaceuticals GmbH's last funding round?
4TEEN4 Pharmaceuticals GmbH's most recent funding round was Grant on July 2, 2026.
Who are the main investors in 4TEEN4 Pharmaceuticals GmbH?
Key investors in 4TEEN4 Pharmaceuticals GmbH include Brandenburg Kapital, Görlich GmbH & Co. 1. BioTech KG.
Will 4TEEN4 Pharmaceuticals GmbH IPO soon?
No public IPO plans have been announced for 4TEEN4 Pharmaceuticals GmbH.
How can I track 4TEEN4 Pharmaceuticals GmbH secondary market activity?
Caplight tracks bids, offers, and trades in 4TEEN4 Pharmaceuticals GmbH's shares on secondary markets.